Observational studyClinical rheumatology2017

Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study.

Maddalena Napolitano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.